Cardiology News | Cardiology Today

CHD AND PREVENTION Gene dosage of 9p21 linked with coronary atheromatous burden severity Gene dosage of the risk variant 9p21 predicted coronary artery disease burden in a new study appearing in the Journal of the American College of Cardiology. The Ottawa researchers performed this cross-sectional study on nondiabetic patients with CAD defined by coronary angiography having at least one epicardial stenosis >50%. They enrolled 950 patients with early onset ... FULL STORY

CHD AND PREVENTION

Gene dosage of 9p21 linked with coronary atheromatous burden severity

Gene dosage of the risk variant 9p21 predicted coronary artery disease burden in a new study appearing in the Journal of the American College of Cardiology.

The Ottawa researchers performed this cross-sectional study on nondiabetic patients with CAD defined by coronary angiography having at least one epicardial stenosis >50%. They enrolled 950 patients with early onset ...
FULL STORY

December 8, 2010 EUROECHO 2010 COPENHAGEN, Denmark more information>>
October 16, 2010 Acute Cardiac Care 2010 Copenhagen, Denmark more information>>
October 13, 2010 World Stroke Congress (CME) Seoul, Korea - Republic of more information>>

December 8, 2010
EUROECHO 2010
COPENHAGEN, Denmark
more information>>

October 16, 2010
Acute Cardiac Care 2010
Copenhagen, Denmark
more information>>

October 13, 2010
World Stroke Congress (CME)
Seoul, Korea - Republic of
more information>>

See complete calendar listings. »

QUOTE OF THE WEEK "Dedicated and empowered patients are likely to be more adherent to treatment for chronic diseases, including hypertension...." Click here to read full article.

QUOTE OF THE WEEK

"Dedicated and empowered patients are likely to be more adherent to treatment for chronic diseases, including hypertension...."

Click here to read full article.

VASCULAR MEDICINE/INTERVENTION Relationship found between CYP2C19 and increased platelet reactivity in patients receiving clopidogrel Carriage of cytochrome 2C19 variant was directly related to increased platelet reactivity and predicted the risk for high post-treatment platelet reactivity in patients who were treated with percutaneous coronary intervention and received high maintenance-dose clopidogrel, study findings suggested. Korean researchers obtained this finding by examining patients (n=126) who had received high maintenance-dose clopidogrel (Plavix, Sanofi-Aventis) after PCI from previously registered Gyeongsang National University Hospital data. Researchers determined plate... FULL STORY

VASCULAR MEDICINE/INTERVENTION

Relationship found between CYP2C19 and increased platelet reactivity in patients receiving clopidogrel

Carriage of cytochrome 2C19 variant was directly related to increased platelet reactivity and predicted the risk for high post-treatment platelet reactivity in patients who were treated with percutaneous coronary intervention and received high maintenance-dose clopidogrel, study findings suggested.

Korean researchers obtained this finding by examining patients (n=126) who had received high maintenance-dose clopidogrel (Plavix, Sanofi-Aventis) after PCI from previously registered Gyeongsang National University Hospital data. Researchers determined plate...

FULL STORY